Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Biopharm segments. The Diabetes and Obesity Care segment includes insulin, GLP-1 and related delivery systems, oral antidiabetic products (OAD), obesity, and other serious chronic diseases. The Biopharm segment focuses on rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.

International Stem Cell Corp. operates as a clinical stage biotechnology company. The firm engages in the development of therapeutic and biomedical products. It operates through the following segments: Cosmetic Market, Biomedical Market and Therapeutic Market. The Cosmetic Market segment develops, manufactures and markets cosmetic skin care products based on the company's proprietary parthenogenetic stem cell technology and targeted small molecule technology. The Biomedical Market segment is involved in the development, manufacture and commercialization of primary human cell research products. The Therapeutic Market segment focuses on the research and development of human parthenogenetic stem cells for the treatment of diseases of the central nervous system, liver diseases and is currently conducting clinical trials for the treatment of Parkinson's disease. The company was founded by William B. Adams, Kenneth C. Aldrich and Gregory S. Keller in June 2005 and is headquartered in San Diego, CA.

Ocata Therapeutics, Inc. is a clinical stage biotechnology company focused on the development and commercialization of Regenerative Ophthalmology therapeutics. Ocata’s most advanced products are in clinical trials for the treatment of Stargardt’s macular degeneration, dry age-related macular degeneration, and myopic macular degeneration. Ocata’s intellectual property portfolio includes pluripotent stem cell platforms – hESC and induced pluripotent stem cell (iPSC) – and other cell therapy research programs.

Massachusetts General Hospital was established to provide care to Boston's sick, regardless of socioeconomic status—an innovative idea in 1811. In the words of their founder, John Warren, MD, “When in distress, every man becomes their neighbor.” They subsequently became the first teaching hospital for Harvard University’s new medical school and have been redefining excellence in healthcare ever since. They have remained at the forefront of medicine by fostering a culture of collaboration, pushing the boundaries of medical research, educating the brightest medical minds and maintaining an unwavering commitment to the diverse community they were created to serve. They believe that because of diversity they excel, through inclusion they respect their community, and with a keen focus on equity they serve, heal, educate and innovate at the highest levels. Their first priority is the well-being of their patients—near and far. As a team they are able to maintain a singular focus on providing the highest quality, most compassionate care to each and every patient.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Schering AG was a research-centered German multinational pharmaceutical company headquartered in Wedding, Berlin, which operated as an independent company from 1851 to 2006. In 2006 it was bought by Bayer AG and merged to form the Bayer subsidiary Bayer Schering Pharma AG, which was renamed Bayer HealthCare Pharmaceuticals in 2011. Schering was listed on the Frankfurt Stock Exchange and had 26,000 employees as of 2004.

Firmenich, Inc. produces beauty, household and fabric care products. It also produces pharmaceuticals food and drinks. The company was founded in 1985 and is headquartered in Plainsboro, NJ

Tianjin Limu Biotechnology Co., Ltd., established on 2016-12-27, Business scope includes livestock and poultry breeding,farming(Operation of branches outside the restricted area);Livestock and poultry breeding technology development,technical consulting,Technical Services,technology transfer;fresh meat,food(With business license),Sales of edible agricultural products;Self-operated and agent goods and technology import and export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

The Institut national de la recherche agronomique (INRA, pronounced [inʁa]; English: National Institute of Agricultural Research) is a French public research institute dedicated to agricultural science. It was founded in 1946 and is a Public Scientific and Technical Research Establishment under the joint authority of the Ministries of Research and Agriculture.

Vitrolife Sweden AB, a subsidiary of Vitrolife AB, is a Swedish company located in V��stra Fr��lunda that manufactures biomedical devices. Hans Thomas Axelsson is currently the CEO of the firm.

Peking University Third Hospital is a private company headquartered in Beijing, China, that operates as a clinic.

Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland.

XY LLC develops sex selection technologies for non-human mammals. The company is headquartered in Navasota, TX.

Part of University of Adelaide, Adelaide Research & Innovation Pty Ltd. is an Australian company located in Adelaide. The firm provides analytical research services. Robert Chalmers is the current CEO of the firm.

CooperSurgical offers a full portfolio of medical and surgical products and brands for women's health care that ob/gyns and other clinician.

Develops and commercializes specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions